Chemoradiotherapy for Recurrent T1G3 Bladder Cancer
NCT03274284 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2017-09-11
Summary
To evaluate the short term results of chemoradiation in case of T1G3 BC after BCG failure.
Conditions
Interventions
- COMBINATION_PRODUCT
-
chemoradiation
chemoradiation in case of T1G3 BC after BCG failure.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Ahmed Moeen · [email protected]
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-31
- Primary Completion
- 2019-11-30
- Completion
- 2019-12-31
More Related Trials
-
Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer
NCT00696579 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
NCT00002490 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Use of BCG and Interferon Alpha in Bladder Cancer
NCT00330707 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Surgery and BCG in Treating Patients With Bladder Cancer
NCT00002990 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
NCT02138734 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
NCT02716961 ·Status: UNKNOWN ·Phase: NA
-
Biological Therapy in Treating Patients With Bladder Cancer
NCT00003779 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma
NCT03324282 ·Status: TERMINATED ·Phase: PHASE2
-
Skipping BCG for T1a Urinary Bladder Tumor.
NCT04298073 ·Status: UNKNOWN
-
A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy
NCT07342517 ·Status: WITHDRAWN ·Phase: PHASE3
-
Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer
NCT03528694 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
NCT00023842 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.
NCT07268339 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
NCT06324058 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
NCT06241755 ·Status: RECRUITING ·Phase: PHASE3
-
Intravesical BCG: is the Urinary Bladder Ready to Receive it
NCT05335512 ·Status: NOT_YET_RECRUITING
-
Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.
NCT00330499 ·Status: COMPLETED ·Phase: PHASE3
-
Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy
NCT03993249 ·Status: UNKNOWN ·Phase: PHASE2
-
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
NCT06120374 ·Status: RECRUITING
-
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer
NCT00384891 ·Status: TERMINATED ·Phase: PHASE3
-
Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer
NCT03892642 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer
NCT00003759 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
NCT05626101 ·Status: RECRUITING ·Phase: NA
-
Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer
NCT02688348 ·Status: WITHDRAWN ·Phase: NA